drugset / Trial / NCT07333170

Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.

NCT07333170

Phase 4 Not yet recruiting 86 enrolled PAEC General Hospital, Islamabad PAEC general hospital · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Pityriasis versicolor is a common superficial fungal infection caused by Malassezia species, characterized by hypo- or hyper-pigmented scaly patches on the skin. Topical antifungal agents are the mainstay of treatment. Ketoconazole has been widely used; however, newer agents such as luliconazole may offer improved efficacy and shorter treatment duration. This randomized controlled study aims to compare the efficacy and safety of topical luliconazole versus topical ketoconazole in patients with pityriasis versicolor. Treatment response will be assessed clinically and mycologically to determine comparative outcomes.

Timeline

Start
2026-02
Primary completion
2026-07
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 2 % Topical
Subject Luliconazole Small molecule 1 % Topical

Indications